CNS Pharmaceuticals, Inc. (CNSP)

NCM – Real Time Price. Currency in USD

5.11

-0.39 (-7.09%)

Market open: Aug 12, 2026, 2:19 PM EDT

5.50

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

12.08.2026

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Company reports approximately $20.0 million cash position and extended operating runway following oversubscribed $22.5 million financing, as it advances its pivot toward a diversified, high-value pipeline HOUSTON, TX / ACCESS Newswire / August 12, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2026 and provided an update on the corporate strategy the company introduced in March 2026. "We are moving with speed and discipline to transform this company," said Rami Levin, President and Chief Executive Officer of CNS Pharmaceuticals.

Videos

No Data

There is no data to display

Press releases

12.08.2026

CNS Pharmaceuticals, Inc. (CNSP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Videos

No Data

Press releases

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Videos

No Data

Press releases

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Search stocks

CNS Pharmaceuticals, Inc. (CNSP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Videos

No Data

Press releases

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Videos

No Data

Press releases

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation